The PI3K/Akt Pathway Mediates the Expression of Type I Collagen Induced by TGF-β2 in Human Retinal Pigment Epithelial Cells

Overview

Journal Graefes Arch Clin Exp Ophthalmol

Specialty Ophthalmology

Date 2011 Aug 23

PMID 21858467

Citations 35

Authors

Katsuhiko Yokoyama

Kenichi Kimoto

Yuji Itoh

Kazuo Nakatsuka

Noritaka Matsuo

Hidekatsu Yoshioka

Toshiaki Kubota

Affiliations

Soon will be listed here.

Abstract

Purpose: Transforming growth factor (TGF)-β is a key mediator of proliferative vitreoretinopathy, but the cellular mechanisms by which TGF-β induces extracellular matrix protein (ECM) synthesis are not fully understood. This study examined whether the PI3K/Akt pathway is involved in TGF-β2-induced collagen expression in human retinal pigment epithelial cells.

Methods: Human retinal pigment epithelial cells ARPE-19 were cultured and stimulated with TGF-β2. The role of the PI3K/Akt pathway was evaluated using the biochemical inhibitor, wortmannin. The effect of wortmannin on the expression of type I collagen mRNA (COL1A1, COL1A2) induced by TGF-β2 was evaluated by real-time RT-PCR. The effect of wortmannin on the synthesis of type I collagen induced by TGF-β2 was assessed by an immunocytochemical analysis with anti-type I collagen antibody. Luciferase reporter assays were performed to examine the effect of wortmannin on the transcriptional activities of COL1A2. A luciferase assay using a mutation construct of the Smad binding site in COL1A2 promoter (Smad-mut/Luc) was also performed to examine the crosstalk between the Smad pathway and the PI3K/Akt pathway. The effects of wortmannin on the transcriptional activity of Smad3 were also examined using CAGA12-Luc. Moreover, the effect of wortmannin on TGF-β2-induced Smad7 mRNA expression was evaluated.

Results: The biochemical blockade of PI3K/Akt activation inhibited TGF-β2-induced type I collagen mRNA expression and type I collagen synthesis. The blockade of PI3K/Akt pathway inhibited the increase in COL1A2 promoter activities when induced by TGF-β2 and reduced TGF-β2 induction of Smad-mut/Luc promoter activity and CAGA12-Luc activity. Moreover, wortmannin increased the TGF-β2-induced Smad7 mRNA expression levels.

Conclusions: The PI3K/Akt pathway plays a role in relaying the TGF-β2 signal to induce type I collagen synthesis in the retinal pigment epithelium through Smad-dependent and Smad-independent pathways.

Citing Articles

Fibrotic Changes in Rhegmatogenous Retinal Detachment.

Harju N, Kauppinen A, Loukovaara S Int J Mol Sci. 2025; 26(3).

PMID: 39940795 PMC: 11817287. DOI: 10.3390/ijms26031025.

Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis.

Singh P, Sun J, Cavalera M, Al-Sharify D, Matthes F, Barghouth M Nat Commun. 2024; 15(1):10464.

PMID: 39653743 PMC: 11628557. DOI: 10.1038/s41467-024-50753-8.

Collagen-disruptive cell therapy: adoptive transfer of membrane-anchored, tumor cell surface vimentin-targeted interleukin 12-armed TILs suppress collagen expression to boost deep T-cell infiltration via dual signaling activation and significant....

Li S Res Sq. 2024; .

PMID: 39574893 PMC: 11581118. DOI: 10.21203/rs.3.rs-5104493/v1.

Knockdown of HSPA13 Inhibits TGFβ1-Induced Epithelial-Mesenchymal Transition of RPE by Suppressing the PI3K/Akt Signaling Pathway.

Gao F, Li M, Zhu L, Li J, Xu J, Jia S Invest Ophthalmol Vis Sci. 2024; 65(11):1.

PMID: 39226050 PMC: 11373707. DOI: 10.1167/iovs.65.11.1.

Reduction in systemic muscle stress markers after exercise-induced muscle damage following concurrent training and supplementation with specific collagen peptides - a randomized controlled trial.

Bischof K, Stafilidis S, Bundschuh L, Oesser S, Baca A, Konig D Front Nutr. 2024; 11:1384112.

PMID: 38590831 PMC: 10999617. DOI: 10.3389/fnut.2024.1384112.

References

Liu X, Hu H, Yin J . Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int. 2006; 26(1):8-22. DOI: 10.1111/j.1478-3231.2005.01192.x. View

Hubchak S, Sparks E, Hayashida T, Schnaper H . Rac1 promotes TGF-beta-stimulated mesangial cell type I collagen expression through a PI3K/Akt-dependent mechanism. Am J Physiol Renal Physiol. 2009; 297(5):F1316-23. PMC: 2781339. DOI: 10.1152/ajprenal.00345.2009. View

Nakao A, Afrakhte M, Moren A, Nakayama T, Christian J, Heuchel R . Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 1997; 389(6651):631-5. DOI: 10.1038/39369. View

Chen S, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J . Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J Invest Dermatol. 1999; 112(1):49-57. DOI: 10.1046/j.1523-1747.1999.00477.x. View

Wang B, Omar A, Angelovska T, Drobic V, Rattan S, Jones S . Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts. Am J Physiol Heart Circ Physiol. 2007; 293(2):H1282-90. DOI: 10.1152/ajpheart.00910.2006. View

Grisanti S, Guidry C . Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci. 1995; 36(2):391-405. View

Connor Jr T, Roberts A, Sporn M, Danielpour D, Dart L, Michels R . Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest. 1989; 83(5):1661-6. PMC: 303874. DOI: 10.1172/JCI114065. View

Hiscott P, Sheridan C, Magee R, Grierson I . Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res. 1999; 18(2):167-90. DOI: 10.1016/s1350-9462(98)00024-x. View

Poncelet A, de Caestecker M, Schnaper H . The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int. 1999; 56(4):1354-65. DOI: 10.1046/j.1523-1755.1999.00680.x. View

10.

Pastor J . Proliferative vitreoretinopathy: an overview. Surv Ophthalmol. 1998; 43(1):3-18. DOI: 10.1016/s0039-6257(98)00023-x. View

11.

Kimoto K, Nakatsuka K, Matsuo N, Yoshioka H . p38 MAPK mediates the expression of type I collagen induced by TGF-beta 2 in human retinal pigment epithelial cells ARPE-19. Invest Ophthalmol Vis Sci. 2004; 45(7):2431-7. DOI: 10.1167/iovs.03-1276. View

12.

Derynck R, Zhang Y . Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003; 425(6958):577-84. DOI: 10.1038/nature02006. View

13.

Kita T, Hata Y, Arita R, Kawahara S, Miura M, Nakao S . Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target. Proc Natl Acad Sci U S A. 2008; 105(45):17504-9. PMC: 2582249. DOI: 10.1073/pnas.0804054105. View

14.

Krupsky M, Fine A, Kuang P, Berk J, Goldstein R . Regulation of type I collagen production by insulin and transforming growth factor-beta in human lung fibroblasts. Connect Tissue Res. 1996; 34(1):53-62. DOI: 10.3109/03008209609028893. View

15.

MACHEMER R . Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture. Invest Ophthalmol Vis Sci. 1988; 29(12):1771-83. View

16.

Border W, Noble N . Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994; 331(19):1286-92. DOI: 10.1056/NEJM199411103311907. View

17.

Cantley L . The phosphoinositide 3-kinase pathway. Science. 2002; 296(5573):1655-7. DOI: 10.1126/science.296.5573.1655. View

18.

Ignotz R, Endo T, Massague J . Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem. 1987; 262(14):6443-6. View

19.

Runyan C, Schnaper H, Poncelet A . The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem. 2003; 279(4):2632-9. DOI: 10.1074/jbc.M310412200. View

20.

Bian Z, Elner S, Yoshida A, Elner V . Differential involvement of phosphoinositide 3-kinase/Akt in human RPE MCP-1 and IL-8 expression. Invest Ophthalmol Vis Sci. 2004; 45(6):1887-96. DOI: 10.1167/iovs.03-0608. View